Skip to Content

PACE Large Co Value Equity P PCLVX

Medalist Rating as of | See UBS Investment Hub
  • NAV / 1-Day Return 20.21  /  +0.80 %
  • Total Assets 783.2 Mil
  • Adj. Expense Ratio
    0.890%
  • Expense Ratio 0.890%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 10,000
  • Status Open
  • TTM Yield 1.83%
  • Turnover 42%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0

Morningstar’s Analysis PCLVX

Will PCLVX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

PACE Large Co Value Equity P's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PCLVX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 34.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Merck & Co Inc

4.22 21.1 Mil
Healthcare

JPMorgan Chase & Co

3.94 19.7 Mil
Financial Services

UnitedHealth Group Inc

3.57 17.8 Mil
Healthcare

Unilever PLC ADR

3.49 17.4 Mil
Consumer Defensive

Rio Tinto PLC ADR

3.36 16.8 Mil
Basic Materials

Gilead Sciences Inc

3.31 16.5 Mil
Healthcare

Gaming and Leisure Properties Inc

3.24 16.2 Mil
Real Estate

Pfizer Inc

3.20 16.0 Mil
Healthcare

General Dynamics Corp

3.20 16.0 Mil
Industrials

Philip Morris International Inc

3.08 15.4 Mil
Consumer Defensive